Psoriasis Associated With Sexual Dysfunction
People with psoriasis may be at increased risk of sexual dysfunction, particularly when they also suffer from mood disorders or arthritis, a research review suggests
People with psoriasis may be at increased risk of sexual dysfunction, particularly when they also suffer from mood disorders or arthritis, a research review suggests
A research team led by Tufts University engineers has developed a non-invasive method for detecting bladder cancer that might make screening easier and more accurate than current invasive clinical tests involving visual inspection of the bladder
The most popular YouTube videos on prostate cancer often offer misleading or biased medical information that poses potential health risks to patients, an analysis of the social media platform shows. Led by researchers at NYU School of Medicine and its Perlmutter Cancer Center, the study of the 150 most-viewed YouTube videos on the disease found that 77 percent had factual errors or biased content in either the video or its comments section
The National Institutes of Health (NIH) is funding a clinical trial to see the safety and effectiveness of a new male contraceptive that would be available in gel formulation
Studies have repeatedly linked maternal smoking during pregnancy with reduced sperm counts in male offspring. Now a research team at Lund University in Sweden has discovered that of nicotine exposure from the mother, whose fathers smoked at the time of pregnancy had half as many sperms as those with non-smoking fathers
Patients with a certain drug-resistant urinary tract infection were more likely to have a relapse of their infection within a week than those with non-resistant infections and were more likely to be prescribed an incorrect antibiotic according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America
A new study has identified a novel molecular driver of lethal prostate cancer, along with a molecule that could be used to attack it. The findings were made in laboratory mice. If confirmed in humans, they could lead to more effective ways to control certain aggressive types of prostate cancer, the second-leading cause of cancer death for men in the U.S.
Germline mutations in three DNA-repair genes (ATM and BRCA1/2) are associated with a greater likelihood of grade reclassification in men on active surveillance (AS) for prostate cancer, researchers report
Among women undergoing midurethral mesh sling insertion, the rate of mesh removal at nine years is estimated to be 3.3 percent, according to a study published online Oct. 23 in the Journal of the American Medical Association
At a time when more than half of male infertility cannot be explained by current methods, a new test developed by Androvia LifeSciences is able to measure male fertility. The proprietary Cap-Score Male Fertility Assay is based on research patented by the Travis lab at the Baker Institute for Animal Health and Cornell University's College of Veterinary Medicine and was recently the subject of a study that appeared Sept. 24 in the journal Molecular Reproduction and Development
Cancer screening has contributed substantially to reduced incidence, morbidity, and mortality, but issues like access and quality care and have kept screening from fulfilling its full potential, according to a new report. The report, published in CA: A Cancer Journal for Clinicians, is the latest installment in the ACS's blueprint for cancer control. The authors summarize the status of cancer screening and propose key areas where attention is needed to further advance screening's contribution to cancer control
Men presenting with aggressive prostate cancer—Gleason Score of 9 or 10—comprise most of those who will die from prostate cancer worldwide, and despite surgical removal of the prostate (radical prostatectomy), their cancer will recur more than 80 percent of the time